Coronary artery disease
-
Extracorporeal membrane oxygenation (ECMO) uses cardiopulmonary bypass technology to provide prolonged cardiac or respiratory support in the intensive care unit. The use of ECMO for neonatal respiratory failure is now good evidence-based medicine following publication of the UK Collaborative ECMO Trial, but its use in adults and children remains controversial. In this review the use of ECMO to support paediatric patients with pre- and post-operative cardiac insufficiency is discussed. The survival with ECMO in these patients is 43-61%, which is remarkable in a group of patients who are moribund prior to initiation of ECMO.
-
Coronary artery disease · Jan 1997
Sequelae of spinal cord stimulation for refractory angina pectoris. Reliability and safety profile of long-term clinical application.
Spinal cord stimulation (SCS) is effective in the treatment of severe coronary artery disease (CAD) unresponsive to anti-anginal medication or revascularization procedures. However, there is still concern about its safety. ⋯ Improvement of the SCS system reduced the equipment-related complication rate. The predictors of outcome are related to the traditional risk factors for CAD. The mortality rate of patients with refractory angina treated with SCS is similar to that of patients with CAD and stable angina pectoris.
-
Coronary artery disease · Jun 1996
Sleep-disordered breathing: a novel predictor of atrial fibrillation after coronary artery bypass surgery.
Sleep-disordered breathing is a common condition associated with nocturnal hypoxaemia, sympathetic activation and haemodynamic stress that can trigger arrhythmias. We examined whether preoperatively diagnosed disordered breathing was associated with an increased incidence of atrial fibrillation after coronary artery bypass surgery. ⋯ Pre-operatively diagnosed sleep-disordered breathing with nocturnal hypoxaemia is an independent predictor of atrial fibrillation after coronary bypass surgery.